4Imamura T, Kiguchi S, Kobayashi K, et al. Effect of ozagrel, a selective thromboxane A2-synthetase inhibitor, on cerebral infarction in rats. Comparative study with norphenazone, a free-radica! scavenger [J]. Arzneimittelforschung,200 ;53 ( 10 ) :688-94.
5Imura Y, Kiyota Y, Nagai Y, et al. Beneficial effect of CV4151 (Is- bogrel), a thromboxane A2 synthase inhibitor, in a rat middle cerebral ar- tery thrombosis mode[J]. Thromb Res, 1995 ;79 ( 1 ) :95-107.
6Kawano K,Ikeda Y,Kondo K,et al. Superiority of platelet integrin GP Ⅱ b- Ⅲ a receptor antagonist over aspirin in preventing cyclic flow reductions in the guinea pig middle cerebral artery[J].Eur J Pharmacol, 1999;374 (3) :377-85.
7Itoh H, Yamatani K, Oshida N, et al. Clinical effects of sodium ozagrel and urokinase in patients with acute cerebral infarction in the territory of the internal carotid artery [J]. No To Shinkei, 1998 ;50 ( 2 ) : 147-55.
